916322-84-4

Basic information

• Product Name: (S)-3-AZIDO-2-(4-METHOXYBENZYL)PROPANAMIDE
• Synonyms: (S)-3-AZIDO-2-(4-METHOXYBENZYL)PROPANAMIDE
• CAS NO: 916322-84-4
• Molecular Formula: C11H14N4O2
• Molecular Weight: 0
• Mol File: 916322-84-4.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (S)-3-AZIDO-2-(4-METHOXYBENZYL)PROPANAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-3-AZIDO-2-(4-METHOXYBENZYL)PROPANAMIDE(916322-84-4)
• EPA Substance Registry System: (S)-3-AZIDO-2-(4-METHOXYBENZYL)PROPANAMIDE(916322-84-4)

Safety Data

• Hazardous Substances Data: 916322-84-4(Hazardous Substances Data)

Usage

Description

(S)-3-AZIDO-2-(4-METHOXYBENZYL)PROPANAMIDE is a chemical compound characterized by the molecular formula C12H16N4O2. It is an amide compound featuring an azido group and a methoxybenzyl substituent, which contributes to its potential applications in various fields.

Uses

Used in Chemical Research and Development:
(S)-3-AZIDO-2-(4-METHOXYBENZYL)PROPANAMIDE is utilized as a key compound in chemical research and development, particularly within the realms of medicinal and pharmaceutical chemistry. Its unique structural features, including the azido group and amide functionality, make it a valuable building block for the synthesis of a wide range of bioactive molecules and drug candidates.
Used in Drug Discovery and Development:
In the pharmaceutical industry, (S)-3-AZIDO-2-(4-METHOXYBENZYL)PROPANAMIDE is employed as an intermediate for the development of new drugs. Its ability to interact with biological targets and serve as a versatile building block for chemical synthesis makes it a promising candidate for creating novel therapeutic agents.
Used in Synthesis of Bioactive Molecules:
(S)-3-AZIDO-2-(4-METHOXYBENZYL)PROPANAMIDE is also used as a starting material for the synthesis of bioactive molecules. Its structural properties allow for the creation of diverse chemical entities that can potentially exhibit various biological activities, making it a valuable asset in the field of drug discovery and development.